Biovica International AB (publ) reported earnings results for the third quarter and nine months ended January 31, 2024. For the third quarter, the company reported sales was SEK 1.08 million compared to SEK 1.29 million a year ago. Revenue was SEK 1.15 million compared to SEK 1.8 million a year ago. Net loss was SEK 27.34 million compared to SEK 28.54 million a year ago. Basic loss per share from continuing operations was SEK 0.44. Diluted loss per share from continuing operations was SEK 0.44.
For the nine months, sales was SEK 5.39 million compared to SEK 3.64 million a year ago. Revenue was SEK 6.06 million compared to SEK 4.36 million a year ago. Net loss was SEK 85.29 million compared to SEK 72.79 million a year ago. Basic loss per share from continuing operations was SEK 1.66. Diluted loss per share from continuing operations was SEK 1.66.